Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-22

Clinical Trial Update: Budesonide for Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial of budesonide for eosinophilic esophagitis has completed. This update confirms the study status as completed and summarizes the trial's progressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)

Snippet

Sponsor: Swiss EE Study Group | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED